Sebastian Szmit: Important Review Published Today By My Research Group
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared on LinkedIn:
”Important review published today by my research group”
This review explores treatment options for venous thromboembolism (VTE) in cancer patients with significant thrombocytopenia (platelet count <50 × 10⁹/L), balancing the need for effective anticoagulation against the increased risk of bleeding.
It outlines strategies such as adjusting anticoagulation doses, using platelet transfusions, or temporarily stopping treatment based on the severity and duration of thrombocytopenia and the patient’s thrombotic risk.
Read the full article here.
Article: Anticoagulant therapy in patients with cancer and thrombocytopenia
Authors: Sebastian Szmit, Jarosław Kępski, Ewa Lech-Marańda, Dariusz M. Kowalski, Maciej Krzakowski, Magdalena Zaborowska-Szmit
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 10, 2026, 14:39Piotr Czempik: ROTEM Guided Anticoagulation in Severe Thrombocytopenia and Acute VTE
-
Sep 10, 2026, 14:30Adil Aftab: Acute VTE Treatment and Anticoagulation Considerations in Renal Dysfunction
-
Sep 10, 2026, 14:21Seth Green: Testosterone Replacement Therapy and VTE Risk When Is the Risk Highest
-
Sep 10, 2026, 13:56Sumyea Kabir: Wet Hijama and Blood Donation Why Deferral Matters
-
Sep 10, 2026, 11:56William Pao: Celebrating a Landmark Breakthrough in Hemophilia Care
-
Sep 10, 2026, 11:25Andreas Glenthøj: New Sickle Cell Trait Data in UpToDate
-
Sep 10, 2026, 10:53A New Era of Hemophilia Screening and Diagnosis in Women and Girls – ISTH
-
Sep 10, 2026, 10:03Investing in Youth, Transforming Hemophilia Care – WFH
-
Sep 10, 2026, 09:51Ronke Oke BEM: 20 Years of Newborn Sickle Cell Screening in England